Cargando…

Clinical efficacy and safety of antifungal drugs for the treatment of Candida parapsilosis infections: a systematic review and network meta-analysis

Antifungal drugs have already been established as an effective treatment option for Candida parapsilosis infections, but there is no universal consensus on the ideal target for clinical efficacy and safety of antifungal drugs for the treatment of C. parapsilosis infections. Few studies have directly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Jielin, Yang, Han, Shan, Zhiming, Jiang, Lingzhi, Zhang, Qingxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2021
Materias:	Prevention, Therapy and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604171/ https://www.ncbi.nlm.nih.gov/pubmed/34633919 http://dx.doi.org/10.1099/jmm.0.001434

Ejemplares similares

Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19
por: Wang, Li, et al.
Publicado: (2021)

Immunogenicity after the first dose of the BNT162b2 mRNA Covid-19 vaccine: real-world evidence from Greek healthcare workers
por: Kontopoulou, Konstantina, et al.
Publicado: (2021)

An antipathogenic compound that targets the OxyR peroxide sensor in Pseudomonas aeruginosa
por: Oh, Hyo-Young, et al.
Publicado: (2021)

CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva
por: Anderson, Enyia R., et al.
Publicado: (2022)

Efficacy and safety of osimertinib in treating EGFR‐mutated advanced NSCLC: A meta‐analysis
por: Yi, Lilan, et al.
Publicado: (2019)

Aneuploidy enables cross-tolerance to unrelated antifungal drugs in Candida parapsilosis
por: Sun, Liu-liu, et al.
Publicado: (2023)

Phase Ib/II study of safety and efficacy of low‐dose decitabine‐primed chemoimmunotherapy in patients with drug‐resistant relapsed/refractory alimentary tract cancer
por: Chen, Meixia, et al.
Publicado: (2018)

Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms
por: Bezerra, Leandro P., et al.
Publicado: (2022)

Antifungal Susceptibility Analysis of Clinical Isolates of Candida parapsilosis in Iran
por: LOTFALI, Ensieh, et al.
Publicado: (2016)

Global Prevalence of Antifungal-Resistant Candida parapsilosis: A Systematic Review and Meta-Analysis
por: Yamin, Dina, et al.
Publicado: (2022)

Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris: Results from a Phase 2 Trial
por: Vazquez, Jose A., et al.
Publicado: (2023)

Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East
por: Ascierto, Paolo Antonio, et al.
Publicado: (2021)

Candida parapsilosis sensu stricto Antifungal Resistance Mechanisms and Associated Epidemiology
por: Franconi, Iacopo, et al.
Publicado: (2023)

Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial
por: Innominato, Pasquale F., et al.
Publicado: (2020)

Candida parapsilosis Candidemia Resistance Patterns and Treatment Outcomes: An Opportunity for Antifungal Stewardship
por: Fong, Gary, et al.
Publicado: (2017)

Characterization of the transcriptional response of Candida parapsilosis to the antifungal peptide MAF-1A
por: Cheng, Rong, et al.
Publicado: (2020)

Antifungal Effect and Inhibition of the Virulence Mechanism of D-Limonene against Candida parapsilosis
por: Leite-Andrade, Melyna Chaves, et al.
Publicado: (2022)

In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
por: Tetz, G., et al.
Publicado: (2019)

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or metastatic breast cancer: Results of the single‐arm, phase IIIB 4EVER trial
por: Tesch, Hans, et al.
Publicado: (2018)

146. antifungal Susceptibility Patterns of candida Parapsilosis Bloodstream Isolates in the US, 2008–2018
por: Tesini, Brenda L, et al.
Publicado: (2020)

Candida parapsilosis Virulence and Antifungal Resistance Mechanisms: A Comprehensive Review of Key Determinants
por: Branco, Joana, et al.
Publicado: (2023)

Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner
por: Papp, Csaba, et al.
Publicado: (2020)

Monthly malaria chemoprevention shows potential in an area of very high, perennial malaria transmission
por: Cairns, Matthew, et al.
Publicado: (2015)

A mandibular advancement device did not affect daytime sleepiness and quality of life in obstructive sleep apnoea
por: Doff, Michiel H J
Publicado: (2015)

Autoinflation reduces middle ear effusion in children with otitis media with effusion
por: Bidarian-Moniri, Armin
Publicado: (2016)

Dihydroartemisinin–piperaquine holds promise as an option for malaria prevention in pregnancy
por: Hill, Jenny, et al.
Publicado: (2016)

Antifungal-Loaded Calcium Sulfate Beads as a Potential Therapeutic in Combating Candida auris
por: Butcher, Mark C., et al.
Publicado: (2022)

A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors
por: Weekes, Colin, et al.
Publicado: (2019)

Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma
por: Iida, Noriho, et al.
Publicado: (2019)

Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Bempegaldesleukin (BEMPEG; NKTR‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma
por: Hennessy, Marlene, et al.
Publicado: (2020)

Systemic Candida parapsilosis Infection Model in Immunosuppressed ICR Mice and Assessing the Antifungal Efficiency of Fluconazole
por: Wu, Yu'e, et al.
Publicado: (2015)

Invasive Candida parapsilosis Bloodstream Infections in Children: The Antifungal Susceptibility, Clinical Characteristics and Impacts on Outcomes
por: Wang, Yao-Sheng, et al.
Publicado: (2023)

The antifungal effect induced by itraconazole in Candida parapsilosis largely depends on the oxidative stress generated at the mitochondria
por: Muñoz-Megías, Mª Luz, et al.
Publicado: (2023)

Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane‐ and trastuzumab‐naïve patients with HER2‐positive, previously treated, advanced, or recurrent gastric cancer (JFMC45‐1102)
por: Nishikawa, Kazuhiro, et al.
Publicado: (2016)

Dosing targeted and cytotoxic two‐drug combinations: Lessons learned from analysis of 24,326 patients reported 2010 through 2013
por: Nikanjam, Mina, et al.
Publicado: (2016)

Trabectedin use in soft‐tissue sarcoma patients in a real‐world setting: Data from an Italian national drug‐access registry
por: Vincenzi, Bruno, et al.
Publicado: (2022)

Recent Progress in Research on Mitochondrion-Targeted Antifungal Drugs: a Review
por: Qin, Yulin, et al.
Publicado: (2023)

In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris
por: Hager, Christopher L., et al.
Publicado: (2018)

Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019
por: Pham, Fiona Y.‐V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2r889b0p5v74ll437cfqjmpnqo